RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
Health Hope Technology, a Beijing AI healthcare company, completed a $15 million Series A financing led by CITIC Bank International and joined by Renai Capital. Founded in 2014, Health Hope has now raised close to $150 million. The company’s ego1.0 system focuses on health management, while ego2.0 offers deeper medical knowledge that includes guided consultation, inquiry, disease detection, diagnosis, treatment, execution and follow-up. The company uses the majority of AI technologies to provide its services.
Source: China Biotoday
